Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Journal of the Chinese Medical Association : JCMA|July 17, 2024
Postoperative prognostic nutrition index predicts survival in patients with small bowel adenocarcinoma after surgical resectionChia-Ju Li, Pei-Chang Lee, Kuo-Wei Huang, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2017
A randomized phase II study of gemcitabine plus Z-360, a CCK2 receptor-selective antagonist, in patients with metastatic pancreatic cancer as compared with gemcitabine plus placeboMakoto Ueno, Chung Pin Li, Masafumi Ikeda, et al.
Oncotarget|June 6, 2015
Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trialJack P Wang, Chen-Yi Wu, Yi-Cheng Yeh, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2022
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma - The Taiwan Cooperative Oncology Group T1217 studyLi-Yuan Bai, Chung-Pin Li, Yan-Shen Shan, et al.
World Journal of Gastroenterology|August 10, 2004
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinomaShinn-Jang Hwang, Jiing-Chyuan Luo, Chung-Pin Li, et al.
Therapeutic Advances in Medical Oncology|March 26, 2026
NALIRIFOX versus liposomal irinotecan plus fluorouracil/leucovorin as the second-line chemotherapy in gemcitabine refractory pancreatic adenocarcinoma: a real-world studyWei-Ze Wong, Nai-Jung Chiang, Kuei-Chuan Lee, et al.
Investigational New Drugs|March 7, 2018
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studiesHerbert Hurwitz, Eric Van Cutsem, Johanna Bendell, et al.
ACS Nano|October 15, 2024
Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer ImmunotherapySheng-Liang Cheng, Hsin-Mei Lee, Chung-Pin Li, et al.
Medicine|December 30, 2014
A comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child-Pugh scores of 5 or 6Hung-Hsu Hung, Yee Chao, Yi-You Chiou, et al.
Biomedical Journal|January 3, 2024
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendationYung-Yeh Su, Nai-Jung Chiang, Tai-Jan Chiu, et al.
Pageof 16